Printer Friendly
The Free Library
19,122,084 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

National Cancer Institute -NCI- Purchases Starbridge Hypercomputer to Accelerate Genome Data Research.


Business Editors/Health/Medical Writers/High-Tech Writers

SALT LAKE CITY--(BUSINESS WIRE)--May 10, 2004

Starbridge Solution Shows Unprecedented Performance for

Manipulating Very Large Sets of Genetic Information

Starbridge Systems(R) announced today that the National Cancer Institute's Advanced Biomedical bi·o·med·i·cal
adj.
1. Of or relating to biomedicine.

2. Of, relating to, or involving biological, medical, and physical sciences.
 Computing Center (ABCC ABCC Advanced Biomedical Computing Center
ABCC Atomic Bomb Casualty Commission
ABCC Alcoholic Beverages Control Commission (Massachusetts, USA)
ABCC American Board of Clinical Chemistry
ABCC Association of British Chambers of Commerce
) in Frederick, Md., recently purchased a Starbridge Hypercomputer(R), the first high-end reconfigurable computer acquired for bioscience research. The Starbridge Hypercomputer will serve as an important scientific computational resource In computational complexity theory, a computational resource is a resource used by some computational models in the solution of computational problems.

The simplest computational resources are computation time, the number of steps necessary to solve a problem, and
 and represents a revolutionary leap in high-performance computing High-speed computing, which typically refers to supercomputers used in scientific research.  capabilities.

Starbridge consulted with Dr. Jack Collins of the National Cancer Institute to assess NCI's research needs, and produced a massively parallel See MPP.  and scalable implementation of the Smith Waterman algorithm, which is used to compare sets of genetic data, on the Starbridge Hypercomputer. Starbridge's implementation of the Smith Waterman algorithm enables NCI See Liberate.  to compare genetic data sets of virtually any size in record-breaking time. As part of the final acceptance criteria, Starbridge demonstrated a Smith Waterman comparison of the human X to Y chromosomes. This comparison, which typically requires months of computation time on a cluster, was completed in approximately five days on the Hypercomputer.

"NCI's purchase illustrates the potential for Hypercomputing to accelerate research in the Life Sciences," said Daniel Oswald, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Starbridge Systems. "We expect this to be the first of many grand challenge problems solved by Starbridge Hypercomputers."

Starbridge Systems: The Hypercomputer Company

Utah-based Starbridge Systems was founded in 1998 to advance reconfigurable computing technologies, creating the powerful, high-performance Hypercomputer platforms. Compared with conventional processors, Starbridge's scalable Hypercomputers offer significant advantages in speed, flexibility, versatility and efficiencies of size, weight and power consumption. Starbridge's Viva development environment turns months into minutes by supporting highly parallel expression of algorithms and optimally configuring the Hypercomputer hardware for peak execution of each algorithm.

For a demonstration or for more information, visit www.starbridgesystems.com/smithwaterman or call 801-984-4444.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 10, 2004
Words:311
Previous Article:Device Software Leader -- Wind River -- Responds to TCP Protocol Vulnerabilities.
Next Article:Mediaplex Announces MOJO Publisher Client Wins; Advanced Inventory Management and Targeting Features Attract Online Publishers.



Related Articles
Fellowships, grants, & awards.
Fellowships, grants, & awards.
Fellowships, grants, & awards.
Abortion-cancer link is rejected. (Biomedicine).
FDA APPROVES LORUS/NCI GTI-2040 PHASE II CLINICAL TRIAL.
Cancer and AIDS: National Cancer Institute's investment in research.
NCI Awarded $7m DRMS contract.
Why we are still losing the winnable cancer war.
Formaldehyde: in spotlight's glare.
The NIH ENDGAME consortium.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles